$207 Million is the total value of AlphaCentric Advisors LLC's 166 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EMHY | New | ISHARES INCjp mrgn em hi bd | $305,000 | – | 6,992 | +100.0% | 0.15% | – |
| SHYG | New | ISHARES INC0-5yr hi yl cp | $249,000 | – | 5,660 | +100.0% | 0.12% | – |
| PFF | New | ISHARES TRpfd and incm sec | $187,000 | – | 5,131 | +100.0% | 0.09% | – |
| IPFF | New | ISHARES INCintl pfd stk etf | $182,000 | – | 12,952 | +100.0% | 0.09% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $171,000 | – | 2,250 | +100.0% | 0.08% | – |
| XLI | New | SELECT SECTOR SPDR TRsbi int-inds | $141,000 | – | 1,834 | +100.0% | 0.07% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $130,000 | – | 3,150 | +100.0% | 0.06% | – |
| INDA | New | ISHARES TRmsci india etf | $94,000 | – | 2,766 | +100.0% | 0.05% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $83,000 | – | 826 | +100.0% | 0.04% | – |
| WIP | New | SPDR SER TRftse int gvt etf | $77,000 | – | 1,414 | +100.0% | 0.04% | – |
| TBIO | New | TRANSLATE BIO INC | $69,000 | – | 5,100 | +100.0% | 0.03% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $67,000 | – | 120 | +100.0% | 0.03% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $61,000 | – | 4,000 | +100.0% | 0.03% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $60,000 | – | 4,100 | +100.0% | 0.03% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $53,000 | – | 2,850 | +100.0% | 0.03% | – |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $53,000 | – | 1,400 | +100.0% | 0.03% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $51,000 | – | 550 | +100.0% | 0.02% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $52,000 | – | 3,500 | +100.0% | 0.02% | – |
| EWM | New | ISHARES INCmsci mly etf new | $48,000 | – | 1,823 | +100.0% | 0.02% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $43,000 | – | 4,200 | +100.0% | 0.02% | – |
| VIE | New | VIELA BIO INC | $42,000 | – | 1,500 | +100.0% | 0.02% | – |
| TCRR | New | TCR2 THERAPEUTICS INC | $39,000 | – | 1,900 | +100.0% | 0.02% | – |
| IVA | New | INVENTIVA SAads | $40,000 | – | 3,400 | +100.0% | 0.02% | – |
| PAND | New | PANDION THERAPEUTICS INC | $36,000 | – | 3,100 | +100.0% | 0.02% | – |
| ADCT | New | ADC THERAPEUTICS SA | $33,000 | – | 1,000 | +100.0% | 0.02% | – |
| MYJ | New | BLACKROCK MUNIYIELD N J FD I | $26,000 | – | 1,900 | +100.0% | 0.01% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $25,000 | – | 175 | +100.0% | 0.01% | – |
| MYOK | New | MYOKARDIA INC | $24,000 | – | 175 | +100.0% | 0.01% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $22,000 | – | 225 | +100.0% | 0.01% | – |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $21,000 | – | 3,000 | +100.0% | 0.01% | – |
| NMCO | New | NUVEEN MUN CR OPPORTUNITIES | $14,000 | – | 1,100 | +100.0% | 0.01% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $14,000 | – | 550 | +100.0% | 0.01% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $12,000 | – | 400 | +100.0% | 0.01% | – |
| IFRX | New | INFLARX NV | $13,000 | – | 3,000 | +100.0% | 0.01% | – |
| XNCR | New | XENCOR INC | $4,000 | – | 100 | +100.0% | 0.00% | – |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $2,000 | – | 50 | +100.0% | 0.00% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $1,000 | – | 100 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-03-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB L | 12 | Q3 2023 | 2.9% |
| INTUITIVE SURGICAL INC | 12 | Q3 2023 | 1.3% |
| STEREOTAXIS INC | 12 | Q3 2023 | 1.0% |
| ALLIED MOTION TECHNOLOGIES I | 12 | Q3 2023 | 1.3% |
| AEROVIRONMENT INC | 12 | Q3 2023 | 1.3% |
| OMNICELL COM | 12 | Q3 2023 | 0.9% |
| ACCURAY INC | 12 | Q3 2023 | 0.8% |
| COLLEGIUM PHARMACEUTICAL INC | 12 | Q3 2023 | 1.1% |
| MICROBOT MED INC | 12 | Q3 2023 | 0.5% |
| ISHARES TR | 11 | Q3 2023 | 13.1% |
View AlphaCentric Advisors LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-13 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-03-11 |
| 13F-HR | 2022-03-11 |
View AlphaCentric Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.